A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144639A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/17/2001	EP1144635A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001	EP1144631A2 Insulin-synthesis genes
10/17/2001	EP1144630A2 Human cell signaling proteins (csig)
10/17/2001	EP1144627A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b
10/17/2001	EP1144625A2 Nucleic-acid binding proteins
10/17/2001	EP1144623A1 Method and medicament for inhibiting the expression of a defined gene
10/17/2001	EP1144621A2 Genetic suppressor elements against human immunodeficiency virus
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144613A1 Methods for making proteins containing free cysteine residues
10/17/2001	EP1144609A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144604A1 Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use
10/17/2001	EP1144603A2 Protease
10/17/2001	EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001	EP1144599A2 Amino-modified ribozymes
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144594A1 Transgenic circulating endothelial cells
10/17/2001	EP1144592A2 Substrate for cell growth
10/17/2001	EP1144591A2 Low oxygen culturing of cells
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function
10/17/2001	EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001	EP1144447A2 Tuberculosis diagnostic test
10/17/2001	EP1144446A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease
10/17/2001	EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144441A2 Disintegrin homologs
10/17/2001	EP1144440A2 Neurotransmitter transporter
10/17/2001	EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001	EP1144437A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
10/17/2001	EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144425A1 Derivatives of monosaccharides as cell adhesion inhibitors
10/17/2001	EP1144420A1 Sulfated phosphatidylinositols, their preparation and use
10/17/2001	EP1144414A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/17/2001	EP1144412A1 Immunosuppressive effects of pteridine derivatives
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144015A1 Treating protein-containing liquids
10/17/2001	EP1144013A1 Lactone bearing absorbable polymers
10/17/2001	EP1144009A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/17/2001	EP1144008A1 Modulation of systemic memory t cell trafficking
10/17/2001	EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001	EP1144005A1 Treatment of papillomavirus infections
10/17/2001	EP1144004A1 Her-2 binding antagonists
10/17/2001	EP1144003A1 Methods and devices for delivery of agents to breast milk ducts
10/17/2001	EP1143999A2 Lipoprotein complexes and compositions containing them
10/17/2001	EP1143998A2 Treatment of hypertension
10/17/2001	EP1143997A1 Tumor necrosis factor antagonists and their use in endometriosis
10/17/2001	EP1143996A2 Method of treating chronic cardiac disease
10/17/2001	EP1143995A1 Anti-dandruff composition comprising an antifungal polypeptide
10/17/2001	EP1143994A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
10/17/2001	EP1143993A1 Method of suppressing ongoing acute allograff rejection
10/17/2001	EP1143992A2 Therapeutic compositions containing glutathione analogs
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143990A2 Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections
10/17/2001	EP1143988A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
10/17/2001	EP1143983A1 Spray delivery of cells
10/17/2001	EP1143980A1 Thio-modified aptamer synthetic methods and compositions
10/17/2001	EP1143974A1 Pharmaceutical compositions for alleviating discomfort
10/17/2001	EP1143969A1 Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
10/17/2001	EP1143956A2 Compositions and methods for the treatment of anorectal disorders
10/17/2001	EP1143948A2 Liver-selective glucocorticoid antagonist for treating diabetes
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1143931A1 Pulmonary drug delivery
10/17/2001	EP1143929A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
10/17/2001	EP1143927A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
10/17/2001	EP1143808A2 Ingestible compositions comprising antibacterial agents
10/17/2001	EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation
10/17/2001	EP0871662B1 Product derived from milk substantially free of beta casein from non-human mammals and relative use
10/17/2001	EP0841930B1 Stable solid formulation of enalapril salt and process for preparation thereof
10/17/2001	EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders
10/17/2001	EP0653211B1 Blood coagulation normalizer containing tcf-ii as active ingredient
10/17/2001	EP0633784B2 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
10/17/2001	EP0617706B1 Multivalent antigen-binding proteins
10/17/2001	CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001	CN1318102A OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use
10/17/2001	CN1318099A LY6H gene
10/17/2001	CN1318069A Factor VIIa inhibitors
10/17/2001	CN1317975A Method of using zot or zonulin to inhibit lymphocyte proliferation in antigen-specific manner
10/17/2001	CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination
10/17/2001	CN1317967A Protein formulations
10/17/2001	CN1317958A Microparticle formulation for inhalation
10/17/2001	CN1317952A Improved method for targeted topial treatment of disease
10/17/2001	CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317493A Preparing process and application of undecapeptide
10/17/2001	CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317342A Eye preparation
10/17/2001	CN1317341A Medical application of heptadecapeptide
10/17/2001	CN1073159C Human kunitz-type protease inhibitors and its related method
10/17/2001	CN1073157C 转录因子aprf Transcription factor aprf
10/17/2001	CN1073154C Superoxide dismutase-4
10/17/2001	CN1073119C Method and compsns. for dry powder formulation of interferons
10/17/2001	CN1073117C Antibiotic peptide and prodn. method and use thereof
10/17/2001	CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof

1 ... 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 ... 3163